The South Korean Dravet Syndrome market is on the cusp of a revolutionary change with the advent of gene therapy. As a monogenic disorder caused by a single gene mutation, Dravet syndrome is an ideal candidate for this groundbreaking treatment approach. Gene therapies, which aim to correct the underlying genetic defect, offer the potential for a one-time, curative treatment, fundamentally...